M&A Corner
Oxford Biomedica Completes Acquisition of ABL Europe06 Feb 2024
Oxford BioMedica has completed its acquisition of ABL Europe, strengthening its position as a global cell and gene therapy CDMO.... Continue Reading
|
ArteraAI Raises $20M to Personalize Cancer Therapy With Multimodal AI06 Feb 2024
ArteraAI, a pioneer in multi-modal artificial intelligence (MMAI) for cancer treatment personalization, has secured an additional $20 million in funding,... Continue Reading
|
Radiology AI Marketplace CARPL Secures $6M to Bridge Radiologist Gap with Seamless Integration Tools06 Feb 2024
CARPL, an enterprise imaging AI marketplace, has raised $6 million in funding to streamline the integration of AI tools into... Continue Reading
|
Mesh Bio Bags $3.5M to Bring Digital Twin Tech to Hong Kong, Indonesia, Philippines06 Feb 2024
Singaporean startup Mesh Bio has raised $3.5 million in a Series A funding round led by East Ventures, with participation... Continue Reading
|
Accompany Health Launches with $56M to Care for Low-Income Patients06 Feb 2024
Accompany Health, a Bethesda-based hybrid care provider for low-income patients with complex needs, has launched with $56 million in Series... Continue Reading
|
Apollomed & BASS Medical Partner to Transform Value-Based Care in Northern California06 Feb 2024
Apollo Medical Holdings (NASDAQ: AMEH) and BASS Medical Group are forming a strategic partnership to enhance value-based healthcare in Northern... Continue Reading
|
Talkspace, Bicycle Health Partner to Expand Therapeutic Offerings06 Feb 2024
Teletherapy platform Talkspace and virtual opioid treatment company Bicycle Health are collaborating to broaden access to virtual care. Talkspace’s patients... Continue Reading
|
Endocrinology Company Valendo Health Launches with $4M and Two Provider Partners06 Feb 2024
Valendo Health, a diabetes-focused company, has launched with $4 million in seed funding and partnerships with Cecelia Health and Advanced... Continue Reading
|
Digital Medicine Society Partners with Industry Groups to Develop Evidence Plans for Digital Health.05 Feb 2024
The Digital Medicine Society (DiMe) is partnering with Peterson Health Technology Institute (PHTI) and ZS Associates, among others, to enhance... Continue Reading
|
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner.05 Feb 2024
Novonesis, the result of the successful merger between Novozymes and Chr. Hansen, emerges as a leading global biosolutions partner. With... Continue Reading
|